Jacobs Levy Equity Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $579K | Buy |
51,972
+165
| +0.3% | +$1.84K | ﹤0.01% | 863 |
|
|
2025
Q1 | $637K | Sell |
51,807
-5,289
| -9% | -$65K | ﹤0.01% | 890 |
|
|
2024
Q4 | $639K | Buy |
+57,096
| New | +$639K | ﹤0.01% | 776 |
|
|
2023
Q1 | – | Sell |
-23,692
| Closed | -$35.3K | – | 1032 |
|
|
2022
Q4 | $35.3K | Buy |
+23,692
| New | +$35.3K | ﹤0.01% | 931 |
|